2014 Ophthalmology Innovator Award Presentation

Gil Kliman presents the 2014 Ophthalmology Innovator Award to Mark Forchette, President & CEO of OptiMedica. OptiMedica, with Mark at the helm, is leading the way to developing a entire new market in ophthalmology for femtosecond lasers. Listen to Gil interview Mark on how he got to where he is today. Presenter: Gilbert H. Kliman,…

Read More

CXLO

Presenter: Roy Rubinfeld, MD Dr. Rubinfeld was the first Washington area ophthalmologist to become involved in the care of laser vision correction patients in 1991. He has performed tens of thousands of LASIK and many PRK and other vision correction procedures. View Full Profile

Read More

Cross Linking Market Overview

Presenter: Stephen Slade, MD Stephen Glenn Slade graduated from the University of Texas (Summa Cum Laude, Phi Beta Kappa) with a final, elective year spent at Guy’s Hospital in London. He completed a residency at LSU in New Orleans and fellowships at Baylor College of Medicine and Project ORBIS in New York. View Full Profile

Read More

Eleven Biotherapeutics

Presenter: Abbie C. Celniker, PhD Dr. Celniker brings more than 20 years of proven protein therapeutic expertise to Eleven Biotherapeutics. Prior to joining Eleven, Abbie was CEO of Taligen Therapeutics, which was acquired by Alexion Pharmaceuticals. View Full Profile

Read More

Mimetogen

Presenter: Garth Cumberlidge Garth Cumberlidge has served as the Company’s President, CEO and member of the Board of Directors since September 2005. Dr. Cumberlidge has over 25 years’ experience in the research products, diagnostics and healthcare industries. View Full Profile

Read More

RPS

Presenter: Robert P. Sambursky, MD Robert Sambursky, MD is CEO, and President of RPS Diagnostics (RPS®), an innovative biotechnology company with a proprietary point-of-care diagnostic testing platform to rapidly and accurately diagnose a variety of infectious diseases and inflammatory conditions. View Full Profile

Read More

TearScience

Presenter: Tim Willis Mr. Willis has more than 35 years of medical device industry experience. Tim is an entrepreneur and inventor and has been responsible for the development and launch of 50+ products that today represent over a half billion dollars in annual sales. View Full Profile

Read More

TearLab

Presenter: Elias Vamvakas Mr Vamvakas is the Chairman and CEO of TearLab Corporation. Prior to TearLab, Mr. Vamvakas co-founded TLCVision (NASDAQ/TLCV, TSX/TLC) in 1993 where he served as President and CEO until 2003. View Full Profile

Read More

Dry Eye Market Overview

Edward J Holland, MD explains where we are and where we might be going with Dry Eye, stressing the significance of the Dry Eye problem and the opportunity it presents to the industry. Presenter: Edward Holland, MD Dr. Holland is the Director of Cornea Services at Cincinnati Eye Institute and Professor of Clinical Ophthalmology at…

Read More

Neovista – A Challenging Journey

Versant Ventures Managing Director William J. Link PhD talks about the journey of NeoVista through all of its ups and downs. Ultimately Neovista was able to get its CE Mark, but failed to get approved by the FDA due to a spiral of “stacking” risks. Presenter: William J. Link, PhD Bill was Founder, Chairman and…

Read More

NexisVision Pivots to Develop a Novel Contact Lens Technology

Formed in 2008 NexisVision’s initial target was next generation corneal refractive surgery or in other words, the comfort and function of LASIK without a flap. In the last 18-24 months the company has pivoted to develop a novel contact lens technology. Presenter: Marguerite McDonald, MD Marguerite McDonald, MD, FACS, is a board-certified ophthalmologist offering corneal,…

Read More

Refractec – The Tale of an Evolution in Need of a Revolution

Refractec was really a revolution at the time in terms of reshaping the cornea, but was in need of an evolution of how we think of the cornea. This technology if introduced today would have had an even more robust life. Presenter: Tom Frinzi Thomas Frinzi is Senior Vice President of Abbott’s vision business, which…

Read More